Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Slugger who wrote (7265)	9/22/1998 9:26:00 AM
From: LarryS	Read Replies (1) \| Respond to of 17367

Still don't understand the purpose of another review just days/ weeks before the planned termination of the trial. Maybe a review in late Oct and a final tweaking before the the meno season really gets heavy in late winter?? Or maybe they are doing some changes now and want to see if it makes any changes in the results. At least this winter the trials will be advanced enough that Neuprex will be able to be given immediately after a patient arrives, which seems very important for Neuprex.